Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas
Authors:
- Jos M. J. A. A. StraetmansJSJos M. J. A. A. Straetmans
- Nadine OlthofNONadine Olthof
- 31 July 2009
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 119 (10) , 1951-1957
Abstract
Objectives/Hypothesis: Assessment of the prognostic value of nodal status in relation to human papillomavirus (HPV) status and the various treatment modalities in tonsillar squamous cell carcinomas (TSCC).Study Design: Retrospective 5‐year survival analysis.Methods: A 5‐year follow‐up of disease‐free, disease‐specific, and overall survival in a group of 81 patients with TSCC was conducted. The nodal status and integration of HPV‐DNA in the genome (detected with fluorescence in situ hybridization) as prognostic indicators were examined while correcting for other clinical parameters (smoking habits, alcohol consumption, treatment modality, differentiation, TNM classification).Results: Of TSCCs, 41% were positive for HPV type 16. In these TSCCs, the primary tumor was significantly smaller when compared to HVP‐negative TSCCs (P = .04), whereas the percentage of cases with cervical metastases was identical. In the total population, it was not nodal involvement, but rather HPV manifestation, which was related to patient prognosis. Within the treatment modalities (surgery combined with radiotherapy and radiotherapy alone), neither nodal status nor HPV were prognostic indicators.Conclusions: Since a substantial percentage of TSCCs are HPV‐positive and metastasizes to cervical lymph nodes in less advanced primary tumors, the N status is an unreliable prognostic indicator in TSCCs. HPV is only prognostically relevant in the total tumor population, but loses its value within patient groups receiving a single treatment modality. The value of HPV for prognosis of patients with TSCC requires further study. Laryngoscope, 2009Keywords
This publication has 31 references indexed in Scilit:
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysisInternational Journal of Cancer, 2007
- Carcinoma of the Oropharynx: Factors Affecting OutcomeThe Laryngoscope, 2005
- Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): A natural disease model provides insights into viral carcinogenesisEuropean Journal of Cancer, 2005
- Staging of the neck in patients with head and neck squamous cell cancer: Imaging techniques and biomarkersOral Oncology, 2004
- Human papillomavirus positive squamous cell carcinoma of the oropharynxCancer, 2001
- Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survivalInternational Journal of Cancer, 2000
- Einfluß verschiedener Formen des metastatischen Lymphknotenbefalls auf die Prognose von Plattenepithelkarzinomen im oberen Aerodigestivtrakt*Laryngo-Rhino-Otologie, 1998
- Der Einfluß von Tumorgröße, Lymphknotenbefall und Behandlungsart auf die Prognose des HypopharynxkarzinomsLaryngo-Rhino-Otologie, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958